Vasc Q Laminate Med

The israel based company s vasq device is designed to aid kidney failure patients in need of dialysis by providing external support to reduce fistula failure.

Vasc q laminate med.

A post market surveillance study to assess the safety and effectiveness of vasq value the safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Value vascular access laminate european experience. Laminate has developed vasq a blood vessel support device for. Laminate medical technologies was founded in 2012 by tammy gilon and dr.

Eyal orion who began their work in the rad biomed incubator. 23 2019 prnewswire the israeli start up laminate medical technologies developer of the vasq external vascular support device for arteriovenous fistulas in patients. Listing a study does not mean it has been evaluated by the u s. Laminate medical technologies said today it launched a pivotal fda cleared trial of its vasq implanted blood vessel device designed for patients requiring arteriovenous fistulas as vascular.

On january 19th laminate medical technologies announced that it launched a pivotal fda cleared trial of its vasq implanted blood vessel device designed for patients requiring arteriovenous fistulas as vascular access for hemodialysis. Vasq is the only solution currently available2that addresses both hemodynamic and mechanical stress to create more usable fistulas promote outward dilative remodeling the nitinol external support controls the remodeling at the anastomosis to promote outward wall thickening downstream for eventual use in hemodialysis.